Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
3/4/2026
Eli Lilly Advances New Oral Diabetes Therapy in China
3/4/2026
Sanofi Licenses Sino Biopharm's Transplant Therapy in $135M Upfront De...
3/4/2026
Antengene Strikes $1.1B+ CD19 T-Cell Engager Deal with UCB
3/4/2026
Minwei Biotech's siRNA Therapy MWX401 Cleared for Clinical Trials in C...
3/4/2026
Immunofoco Raises ~CNY 200M in Pre-IPO Round Ahead of Hong Kong Listin...
3/4/2026
Leman Biotech Raises ~CNY 200M to Advance Metabolism-Enhanced CAR-T Pl...
3/4/2026
CDE Issues Technical Guideline on Clinical Trials for Drugs Treating C...
3/4/2026
CDE Invites Feedback on Draft Technical Guideline for Preventive mRNA ...
3/4/2026
CSPC's Emicizumab Injection Receives Clinical Trial Approval in China
3/4/2026
China Biotech Outlicensing Surges Past US$52 Billion in Early 2026
3/3/2026
China Approves Five NMEs in February as Innovation Expands Globally
3/3/2026
Prolium Launches with $50M to Advance China-Licensed T-Cell Engager in...
3/3/2026
Rallybio to Merge with Candid Therapeutics in $505M-Funded Reverse Mer...
3/3/2026
Clickmab Biotech Secures Seed+ Funding to Boost AI Antibody Design Pla...
3/3/2026
LongBio Pharma's LP‑003 Shows Superior Efficacy Over Xolair in Phase ...
3/2/2026
WuXi XDC Partners With Earendil Labs on Next-Generation ADC Platform
3/2/2026
Sanofi Secures Two New China Approvals for Dupilumab
3/2/2026
Innovent Registers Phase I Study for FIC Dual-Payload Bispecific ADC
3/2/2026
NMPA Grants Conditional Approval to Sosimerasib for KRAS G12C-Mutant N...
3/2/2026
NMPA Approves Rovalicitinib for First-Line Myelofibrosis
3/2/2026
QL Biopharm Raises Over CNY 500M in Series C Led by OrbiMed
3/2/2026
MediLink Advances HER3 ADC YL202 Into Two Phase III Trials in China
3/2/2026
RemeGen NDA for RC288 Dual-Target ADC Accepted by NMPA
3/2/2026
CDE Issues Interim Guidelines for Synthetic Oligonucleotide Innovativ...
3/2/2026
China Approves Jaypirca for Expanded Blood Cancer Indications
3/2/2026
2026 Biotech Playbook: Hong Kong at the Centre of China’s Globalisati...
2/28/2026
bioMérieux CEO Flags "Negative Healthcare Market Evolution" in China
2/28/2026
China's Tech Giants Pour Billions Into AI Healthcare Amid Uncertain Bu...
2/28/2026
China-SCO Cooperation Center for Metabolic Diseases Launched in Shangh...
2/28/2026
Recent Executive Moves
Page:
1
/
820
Total number of articles:
24586
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit